HealthTelix, Ekalia Plan Astatine-211 Production at Pennsylvania SiteBy Naomi CalderOct 20, 2026, 2:10 AM UTC
BusinessActinium Names Maenpaa to Lead Licensing and Partnership StrategyBy Helena WardOct 16, 2026, 6:34 PM UTC
HealthAtomVie Partners With Jubilant on U.S. Radiopharma Trial DeliveriesBy Naomi CalderOct 15, 2026, 11:01 PM UTC
BusinessTelix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key ExecutivesBy Nasdaq OMXJan 15, 2018, 2:12 AM UTC
BusinessTelix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing PartnershipBy Nasdaq OMXDec 12, 2017, 10:00 PM UTC
BusinessTelix Pharmaceuticals Limited Lists on the Australian Securities ExchangeBy Nasdaq OMXNov 15, 2017, 1:00 AM UTC
BusinessTelix Pharmaceuticals and CellSight Technologies Conclude Collaboration and License Agreement for VisAcT ImmunoPET TechnologyBy Nasdaq OMXSep 20, 2017, 1:46 AM UTC
BusinessKevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals LimitedBy Nasdaq OMXSep 17, 2017, 10:00 PM UTC
